Detection of cerebral aging, an absolute need: Predictive value of cognitive status

European Neurology

Volumn 39, Issue SUPPL.1, 1998, Pages 2-6

  Forette, Françoise ^a   Seux, Marie Laure ^a   Thijs, Lutgarde ^b   Le Divenah, Aude ^a   Pérol, Marie Bénédicte ^a   Rigaud, Anne Sophie ^a   Latour, Florence ^a   Bouchacourt, Patrice ^a   Staessen, Jan A ^b  

^a Paris Descartes University   (France)

^b UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

Cognitive status; Dementia; Elderly; Systolic hypertension

Indexed keywords

CALCIUM ANTAGONIST;

ADULT; AGE; AGED; AGING; ALCOHOL CONSUMPTION; CARDIOVASCULAR DISEASE; COGNITION; COGNITIVE DEFECT; CONFERENCE PAPER; DIAGNOSTIC VALUE; EDUCATION; FEMALE; FUNCTIONAL ASSESSMENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; MULTIINFARCT DEMENTIA; PREDICTION; PRIORITY JOURNAL; SYSTOLIC BLOOD PRESSURE; SYSTOLIC HYPERTENSION;

AGING; BRAIN; COGNITION DISORDERS; DEMENTIA; DOUBLE-BLIND METHOD; EUROPE; FEMALE; HUMANS; INCIDENCE; MALE; MASS SCREENING; PREDICTIVE VALUE OF TESTS; PSYCHIATRIC STATUS RATING SCALES; RISK FACTORS;

EID: 0031906312     PISSN: 00143022     EISSN: None     Source Type: Journal    
DOI: 10.1159/000052063     Document Type: Conference Paper

References (44)

1. Katzman R, Aranson M, Fuld P, Kawas C, Brown T, Morgenstern H, Frishman W, Gidez L, Eder H, Ooi WL: Development of dementing illnesses in an 80-year-old volunteer cohort. Ann Neurol 1989;25:317-324.
2. de Rotrou J, Forette F, Hervy MP, Tortrat D, Fermanian J, Boudou MR, Boller F: The cognitive efficiency profile: Description and validation in patients with Alzheimer's disease. Int J Geriatr Psychiatry 1991;6:501-509.
3. Dartigues JF, Commenges D, Letenneur L, Barberger-Gateau P, Gilleron V, Fabrigoule C, Mazaux JM, Orgogozo JM, Salamon R: Cognitive predictors of dementia in elderly community residents. Neuroepidemiology 1997;16: 29-39.
4. Forette F, Boller F: Hypertension and risk of dementia in the elderly. Am J Med 1991;90: 14S-19S.
5. Amery A, Birkenhäger W, Bulpitt C, Clement D, De Leeuw P, Dollery CT, Fagard R, Fletcher A, Forette F, Leonetti G, O'Brien ET, O'Malley ET, Rodicio JL, Rosenfeld J, Staessen J, Strasser T, Terzoli L, Thijs L, Tuomilehto J, Webster J: Syst-Eur. A multicenter trial on the treatment of isolated systolic hypertension in the elderly: Objectives, protocol and organization. Aging 1991;3:287-302.
6. Forette F, Amery A, Staessen J, Strasser T, Thijs L, Beevers DG, Clement D, Cox J, De Leeuw PW, De Plaen JF, Donnarel G, Escande M, Fagard R, Gierd X, Gunawardena ND, Perillat J, Ruilope J, Slovick D, Terzoli L, Webster J: Is prevention of vascular dementia possible? The Syst-Eur Vascular Dementia Project. Aging 1991;3:373-382.
7. Folstein MF, Folstein SE, McHugh PR: Mini Mental State: A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-198.
8. Forette F, Henry JF, Orgogozo JM, Pere JF, Hugonot L, Israel L, Loria Y, Goulley F, Lallemand A, Boller F: The reliability of clinical criteria for the diagnosis of dementia: A longitudinal multicentric study. Arch Neurol 1989;46: 646-648.
9. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, ed 3 revised. Washington, American Psychiatric Association, 1987.
10. Loeb C, Gandolfo C: Diagnostic evaluation of degenerative and vascular dementia. Stroke 1983;14:399-401.
11. Staessen J, Fagard R, Thijs L, Celis H, Arabidze GG, Birkenhäger W, Bulpitt C, de Leeuw P, Dollery CT, Fletcher A, Forette F, O'Brien ET, Tuomilehto J, Nachev J, Rosenfeld J, Rodicio JL, Zanchetti A: Morbidity and mortality in the placebo-controlled European trial on isolated systolic hypertension in the elderly. Lancet 1997;350:757-764.
12. Launer LJ: Overview of incidence studies of dementia conducted in Europe. Neuroepidemiology 1992;11(suppl 1):2-13.
13. Roman GC, Tatemichi TK, Erkinjuntti T, Cummings JL, Masdeu JC, Garcia JH, Amaducci L, Orgogozo JM, Brun A, Hofman A, Moody DM, O'Brien MD, Yamaguchi T, Grafman J, Drayer BP, Bennet DA, Fisher M, Ogata J, Kokmen E, Bermejo M, Wolf PA, Gorelick BP, Bick KL, Pajeau AK, Bell MA, DeCarli C, Culebras A, Korczyn AD, Bogousslavsky J, Hartmann A, Scheinberg P: Vascular dementia: Diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology 1993;43:250-260.
14. Forette F, Bert P, Rigaud AS, Gisselbrecht M, Morin M: Assessing vascular dementia. Neth J Med 1995;47:185-194.
15. Commenges D, Gagnon M, Letenneur L, Dartigues JF, Barberger-Gateau P, Salamon R and PAQUID Study Group: Statistical description of the Mini-Mental State Examination for French Elderly Community Residents. J Nerv Ment Dis 1992;180:28-32.
16. Feher EP, Mahurin RK, Doody RS, Coke N, Sims J, Pirozzolo FJ: Establishing the limits of the Mini-Mental State. Arch Neurol 1992;49: 87-92.
17. Mitrushina M, Satz P: Utility of Mini-Mental State Examination in assessing cognition in the elderly. Aging Clin Exp Res 1994;6:427-432.
18. Kokmen E, Beard CM, Chandra V, Offord KP, Schoenberg BS, Ballard DJ: Clinical risk lactors for Alzheimer's disease: A population-based case-control study. Neurology 1991;41: 1393-1397.
19. Hofman A, Ott A, Breteler MM, Bots M, Slooter AJC, van Harskamp F, van Djuin CN, van Broeckhoven C, Grobbee DE: Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer's disease in the Rotterdam Study. Lancet 1997;349:151-154.
20. Frisoni GB, Calebresi L, Geroldi C, Bianchetti A, D'Aquaria AL, Govoni L, Sirtori CR, Trabucchi M, Franceschini G: Apolipoprotein e4 allele in Alzheimer's disease and vascular dementia. Dementia 1994;5:240-242.
21. Kalmijn S, Feskens BJM, Launer LJ, Kromout D: Cerebrovascular disease, the apolipoprotein e4 allele and cognitive decline in a community-based study of elderly men. Stroke 1996;27: 2230-2235.
22. Jorm AF, Korten AE, Henderson AS: The prevalence of dementia: A quantitative integration of the literature. Acta Psychiatr Scand 1987;76:465-479.
23. Rocca WA, Hofman A, Brayne C, Breteler M, Clarke M, Copeland J, Dartigues JF, Engedal K, Hagnell O, Heeren TJ, Jonker C, Lindesay J, Lobo A, Mann AH, Mölsa PK, Morgan K, O'Connor DW, da Sylva Droux A, Sulkava R, Kay D, Amaducci L for the EURODEM-Prevalence Research Group: The prevalence of vascular dementia in Europe: Facts and fragments from 1980-1990 studies. Ann Neurol 1991;30: 817-824.
24. Wernicke TF, Reischies FM: Prevalence of dementia in old ages. Neurology 1994;44:250-253.
25. Bachman DL, Wolf PA, Linn RT, Knoefel JE, Cobb JL, Belanger AJ, White MD, D'Agostino RB: Incidence of dementia and probable Alzheimer's disease in a general population: The Framingham Study. Neurology 1993;43:515-519.
26. Masur D, Sliwinski M, Lipton RB, Blau A, Crystal H: Neuropsychological prediction of dementia and the absence of dementia in healthy elderly persons. Neurology 1994;44: 1427-1432.
27. Tierney MC, Szalai JP, Snow WG, Fisher MB, Nores A, Nadon G, Dunn E, St George-Hyslop PH: Prediction of probable Alzheimer's disease in memory-impaired patients: A prospective longitudinal study. Neurology 1996;46:661-665.
28. Katzman R: Education and the prevalence of dementia and Alzheimer's disease. Neurology 1993;43:13-20.
29. Dartigues JF, Gagnon M, Letenneur L, Barberger-Gateau P, Commenges D, Evaldre M, Salamon R: Principal lifetime occupation and cognitive impairment in a French elderly cohort (Paquid). Am J Epidemiol 1992;135:981-988.
30. Ott A, Breteler M, van Harskamp F, Claus JJ, van der Cammen TJM, Grobbee DE, Hofman A: Prevalence of Alzheimer's disease and vascular dementia: Association with education. The Rotterdam study. BMJ 1995;310:970-973.
31. Stern Y, Gurland B, Tatemichi T, Ming Xin Tang, Wilder T, Mayeux R: Influence of education and occupation on the incidence of Alzheimer's disease. JAMA 1994;271:1004-1010.
32. Mortel KF, Meyer JS, Herod B, Thornby J: Education and occupation as risk factors for dementias of the Alzheimer and ischemic types. Dementia 1995;6:55-62.
33. Roses AD: Apolipoprotein E alleles as risk factors in Alzheimer's disease. Annu Rev Med 1996;47:387-400.
34. Sherwin BB: Estrogenic effects on memory in women. Ann NY Acad Sci 1994;743:213-231.
35. Barret-Connor E, Kritz-Sylverstein D: Estrogen replacement therapy and cognitive functions in older women. JAMA 1993;269:2637-2641.
36. Paganini-Hill A, Henderson VW: Estrogen deficiency and risk of Alzheimer's disease in women. Am J Epidemiol 1994;140:256-261.
37. Brenner DE, Kukull WA, Stergachis A, van Belle G, Bowen JD, McCormick WC, Teri L, Larson EB: Postmenopausal estrogen replacement therapy and the risk of Alzheimer's disease: A population-based case-control study. Am J Epidemiol 1994;140:262-267.
38. Henderson VW, Watt L, Buckwalter JG: Cognitive skills associated with estrogen replacement in women with Alzheimer's disease. Psychoneuroendocrinology 1996;21:421-430.
39. Paganini-Hill A, Henderson VW: Estrogen replacement therapy and risk of Alzheimer's disease. Arch Intern Med 1996;156:2213-2217.
40. French LR, Schumen LM, Mortimer JA, Hutton JT, Boatman RA, Christians B: A case-control study of dementia of the Alzheimer type. Am J Epidemiol 1985;121:414-421.
41. Millykangas-Luosujarvi R, Isomaki H: Alzheimer's disease and rheumatoid arthritis (letter). Br J Rheumatol 1994;33:501-502.
42. Rich JB, Rasmusson DX, Folstein MF, Carson KA, Kawas C, Brandt J: Non steroidal anti-inflammatory drugs in Alzheimer's disease. Neurology 1995;45:51-55.
43. Andersen K, Launer LJ, Ott A, Hoes AW, Breteler M, Hofman A: Do nonsteroidal anti-inflammatory drugs decrease the risk for Alzheimer's disease? The Rotterdam Study. Neurology 1995;45:1441-1445.
44. Sano M, Ernesto C, Thomas RG, Klauber MR, Schafer K, Grundman M, Woodbury P, Growdon J, Cotman C, Pfeiffer E, Schneider L, Thal L, for the members of the Alzheimer's Disease Cooperative Study: A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. N Engl J Med 1997;336: 1216-1222.